Insider Transactions in Q1 2023 at Silk Road Medical Inc (SILK)
Insider Transaction List (Q1 2023)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Mar 15
2023
|
Elizabeth H Weatherman |
SELL
Open market or private sale
|
Direct |
5,000
-3.24%
|
$205,000
$41.91 P/Share
|
Mar 13
2023
|
Erica J. Rogers President and CEO |
SELL
Open market or private sale
|
Direct |
6,000
-2.18%
|
$252,000
$42.23 P/Share
|
Mar 13
2023
|
Erica J. Rogers President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
6,000
+2.13%
|
$6,000
$1.6 P/Share
|
Mar 06
2023
|
Richard Ruedy EVPClin&Reg.Affairs&QA |
SELL
Open market or private sale
|
Direct |
2,373
-1.6%
|
$111,531
$47.73 P/Share
|
Mar 06
2023
|
Andrew S. Davis Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
3,868
-3.24%
|
$181,796
$47.74 P/Share
|
Mar 03
2023
|
Lucas W. Buchanan COO & CFO |
SELL
Open market or private sale
|
Direct |
9,918
-4.6%
|
$466,146
$47.11 P/Share
|
Mar 03
2023
|
Erica J. Rogers President and CEO |
SELL
Open market or private sale
|
Direct |
18,043
-6.28%
|
$848,021
$47.1 P/Share
|
Mar 02
2023
|
Richard Ruedy EVPClin&Reg.Affairs&QA |
BUY
Grant, award, or other acquisition
|
Direct |
13,341
+8.28%
|
-
|
Mar 02
2023
|
Lucas W. Buchanan COO & CFO |
BUY
Grant, award, or other acquisition
|
Direct |
26,682
+11.02%
|
-
|
Mar 02
2023
|
Kevin M Klemz EVP/Chief Legal Officer/Sec. |
BUY
Grant, award, or other acquisition
|
Direct |
20,011
+33.16%
|
-
|
Mar 02
2023
|
Andrew S. Davis Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
21,346
+15.15%
|
-
|
Mar 02
2023
|
Erica J. Rogers President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
40,976
+12.49%
|
-
|
Mar 01
2023
|
Andrew S. Davis Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
6,753
-3.26%
|
$324,144
$48.02 P/Share
|
Mar 01
2023
|
Andrew S. Davis Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,753
+3.11%
|
$27,012
$4.73 P/Share
|
Feb 15
2023
|
Elizabeth H Weatherman |
SELL
Open market or private sale
|
Direct |
5,000
-3.14%
|
$245,000
$49.86 P/Share
|
Feb 13
2023
|
Erica J. Rogers President and CEO |
SELL
Open market or private sale
|
Direct |
6,000
-2.38%
|
$300,000
$50.94 P/Share
|
Feb 13
2023
|
Erica J. Rogers President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
6,000
+2.32%
|
$6,000
$1.6 P/Share
|
Feb 01
2023
|
Andrew S. Davis Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
6,753
-6.43%
|
$364,662
$54.05 P/Share
|
Feb 01
2023
|
Andrew S. Davis Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,753
+6.05%
|
$27,012
$4.73 P/Share
|
Feb 01
2023
|
Tony M. Chou |
SELL
Open market or private sale
|
Direct |
13,008
-14.66%
|
$715,440
$55.0 P/Share
|
Jan 19
2023
|
Lucas W. Buchanan COO & CFO |
SELL
Open market or private sale
|
Direct |
41,244
-6.51%
|
$2,185,932
$53.4 P/Share
|
Jan 19
2023
|
Lucas W. Buchanan COO & CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
38,528
+8.24%
|
$385,280
$10.8 P/Share
|
Jan 17
2023
|
Lucas W. Buchanan COO & CFO |
SELL
Open market or private sale
|
Direct |
45,000
-19.03%
|
$2,430,000
$54.68 P/Share
|
Jan 17
2023
|
Lucas W. Buchanan COO & CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
45,000
+15.98%
|
$45,000
$1.6 P/Share
|
Jan 17
2023
|
Elizabeth H Weatherman |
SELL
Open market or private sale
|
Direct |
56,355
-26.11%
|
$3,043,170
$54.69 P/Share
|
Jan 13
2023
|
Tony M. Chou |
SELL
Open market or private sale
|
Direct |
806
-0.91%
|
$44,330
$55.0 P/Share
|
Jan 12
2023
|
Tony M. Chou |
SELL
Open market or private sale
|
Direct |
200
-0.23%
|
$11,000
$55.0 P/Share
|
Jan 11
2023
|
Erica J. Rogers President and CEO |
SELL
Open market or private sale
|
Direct |
6,000
-2.38%
|
$306,000
$51.53 P/Share
|
Jan 11
2023
|
Erica J. Rogers President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
6,000
+2.32%
|
$6,000
$1.6 P/Share
|
Jan 03
2023
|
Andrew S. Davis Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
6,753
-3.29%
|
$351,156
$52.87 P/Share
|
Jan 03
2023
|
Andrew S. Davis Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,753
+3.16%
|
$20,259
$3.17 P/Share
|